|
at 05:05 |
|
|
MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership that promises to revolutionize the field of next-generation therapies. This collaboration...
|
|
at 05:02 |
|
|
Immunovia AB (publ) today announced that the Annual Report for 2023 has been published.
The annual report can be downloaded in pdf format and is available on Immunovia's website: https://investor.immunovia.com/financial-reports-presentations/.
For...
|
|
at 04:19 |
|
|
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the combination of fostroxacitabine bralpamide (fostrox) + Lenvima® in...
|
|
at 04:15 |
|
|
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the launch of a fully stable cell line development service.
There are now two ways for customers to...
|
|
at 04:07 |
|
|
Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of their innovative bladder cancer treatment companion app in...
|
|
at 04:00 |
|
|
Calibre Scientific is pleased to announce the acquisition of Camlab Limited ("Camlab" or the "Company"), a UK-based supplier of scientific equipment, chemicals, consumables, labware, and other laboratory supplies and services to customers in the...
|
|
|
